ETONEton Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Eton Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ETONThis | $1.6B#2 | — | 35.0x#3 | 20.4x#3 | 104.9%#2 | -20.4%#3 | -1.1%#1 | -9.9%#1 | -1.8%#1 | 4#1 | — | — |
| ZYME | $2.0B#1 | — | 24.3x#2 | 18.4x#2 | 38.9%#3 | 33.9%#1 | -87.3%#2 | -100.9%#3 | — | — | 72.9%#1 | — |
| SNDX | $1.6B#3 | — | 104.5x#4 | 9.2x#1 | 627.8%#1 | 10.5%#2 | -158.4%#3 | -1890.2%#4 | -1205.8%#2 | — | 19.8%#2 | — |
| TYRA | $1.5B#4 | — | 4.1x#1 | — | — | -38.7%#4 | — | -33.9%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice